DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Coleman CI, Baugh C, Crivera C. , et al.
Healthcare costs associated with rivaroxaban or warfarin use for the treatment of venous thromboembolism.
J Med Econ 2017;
20 (02) 200-203
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.